These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8164355)

  • 1. [Action of synthetic progestin].
    Kamada M; Irahara M; Aono T
    Nihon Rinsho; 1994 Mar; 52(3):593-9. PubMed ID: 8164355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity.
    Muhn P; Fuhrmann U; Fritzemeier KH; Krattenmacher R; Schillinger E
    Ann N Y Acad Sci; 1995 Jun; 761():311-35. PubMed ID: 7625729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and noncontraceptive uses of the new, low-dose oral contraceptive.
    Batzer FR
    J Reprod Med; 1984 Jul; 29(7 Suppl):503-12. PubMed ID: 6237195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral micronized progesterone.
    de Lignières B
    Clin Ther; 1999 Jan; 21(1):41-60; discussion 1-2. PubMed ID: 10090424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding activity of 5alpha-reduced gestagens to the progestin receptor from African elephant (Loxodonta africana).
    Meyer HH; Jewgenow K; Hodges JK
    Gen Comp Endocrinol; 1997 Feb; 105(2):164-7. PubMed ID: 9038248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Not all progestins are the same: implications for usage.
    Hapgood JP; Koubovec D; Louw A; Africander D
    Trends Pharmacol Sci; 2004 Nov; 25(11):554-7. PubMed ID: 15491776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological profile of progestins.
    Sitruk-Ware R
    Maturitas; 2004 Apr; 47(4):277-83. PubMed ID: 15063480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between structure and mode of action of 16 alpha, 17 alpha-cycloalkanoprogesterones (pregna-D'-pentaranes).
    Levina IS; Kamernitzky AV; Fanchenko ND; Simonov VI
    Endokrinologie; 1982 Nov; 80(3):266-74. PubMed ID: 7166158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of estrogen and progestin treatments on endometria from postmenopausal women.
    King RJ; Whitehead MI; Campbell S; Minardi J
    Cancer Res; 1979 Mar; 39(3):1094-101. PubMed ID: 427751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of plasminogen activator inhibitor 1 expression by interaction of epidermal growth factor with progestin during decidualization of human endometrial stromal cells.
    Lockwood CJ
    Am J Obstet Gynecol; 2001 Apr; 184(5):798-804; discussion 804-5. PubMed ID: 11303186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
    Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
    Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of synthetic gestagens on progesterone formation in vitro in human corpus luteum of pregnancy.
    Karjalainen O; Saure A; Teravainen T
    ICRS J Int Res Commun; 1974 Jan; 2(1):1017. PubMed ID: 4430395
    [No Abstract]   [Full Text] [Related]  

  • 14. [Progesterone and gestagen treatment. Pharmacologic and clinical aspects].
    Andreasen EE; Andersen HJ; Jensen HK
    Ugeskr Laeger; 1989 Aug; 151(32):2021-6. PubMed ID: 2672497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
    Liang Y; Wu J; Stancel GM; Hyder SM
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of progestins of human proliferative endometrium: an in vitro model of potential clinical relevance.
    Illouz S; Dales JP; Sferlazzo K; Garcia S; Carpentier-Meunier S; Boubli L; Lavaut MN; Charpin C
    Int J Mol Med; 2003 Oct; 12(4):517-23. PubMed ID: 12964029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemical classification of synthetic progestogens].
    Belaisch J
    Rev Fr Gynecol Obstet; 1985 Jun; 80(6 Pt 2):473-7. PubMed ID: 4081503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current status of gestagen administration. 2. Gestagen therapy in the area of reproduction].
    Völker W
    Fortschr Med; 1977 Jan; 95(2):68-70. PubMed ID: 556711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells.
    Krämer EA; Seeger H; Krämer B; Wallwiener D; Mueck AO
    Eur J Obstet Gynecol Reprod Biol; 2006 Nov; 129(1):77-83. PubMed ID: 16460873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of rat uterine steroid receptors by nomegestrol acetate, a new 19-nor-progesterone derivative.
    Botella J; Duc I; Delansorne R; Paris J; Lahlou B
    J Pharmacol Exp Ther; 1989 Feb; 248(2):758-61. PubMed ID: 2918478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.